Positioned as a home assistant, LG CLOiD embodies LG's vision of the "Zero Labor Home, Makes Quality Time" – a future where technology meaningfully reduces the burden of daily chores, allowing ...
The Hong Kong delegation aims to showcase innovation and forge international partnerships at the premier global technology exhibition.
Investing.com - Leerink Partners reiterated an Outperform rating and $16.00 price target on Vir Biotechnology (NASDAQ:VIR) following Mirum’s acquisition of private company Bluejay. VIR shares, ...
The comedian Vir Das, who has gained international fame despite intense criticism in his native India, has taken up boxing. He says it’s “good prep for adversity.” Vir Das, a comedian, feels boxing is ...
The robot, known as AIDOL, staggered onstage during a technology showcase in Moscow. Organizers blamed the mishap on calibration and lighting issues. By Neil Vigdor and Sanjana Varghese It was an ...
Today is shaping up negative for Vir Biotechnology, Inc. (NASDAQ:VIR) shareholders, with the analysts delivering a substantial negative revision to next year's forecasts. Revenue estimates were cut ...
Vir Biotechnology Inc (NASDAQ:VIR) completed enrollment in Eclipse One, their first registrational phase 3 study for hepatitis Delta, ahead of schedule. The company plans to share a comprehensive data ...
Vir’s most advanced program targets Hepatitis Delta, a serious viral infection that dramatically increases the risk of liver-related death, cirrhosis, and cancer. The company’s presentation ...
Robots may be one of the greatest 21st-century inventions, but up until Oct. 28, you couldn’t purchase one to help out with daily household tasks, such as emptying the dishwasher or vacuuming your ...
Marianne De Backer, PhD, MBA, CEO of Vir Biotechnology, has led the company's pivot to focusing on cancer as well as infectious diseases. [Vir Biotechnology] Between launching clinical studies for its ...
Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform recommendation. Analyst Price Forecast Suggests 232.11% Upside As of June ...